Search Results - "Vida, RG"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    5PSQ-125 The identification of health consequences associated with counterfeit medicine and illegal health product application using pharmacovigilance data by Vida, RG, Pozsgai, K, Vajda, P, Botz, L

    “…Background and importanceInformation on the health damage caused by counterfeit medicines and healthcare products is not, or is only rarely found, in the…”
    Get full text
    Journal Article
  3. 3

    4CPS-112 Survey of dietary supplement use and vaccination status among rheumatoid arthritis patients during the COVID-19 pandemic by Vida, RG, Auer, M, Jancsó, M, Schaadt, N, Somogyi-Végh, A, Botz, L

    “…Background and ImportanceIn recent years not just the novel therapeutic approaches, but the Coronavirus pandemic has also affected the therapy management of…”
    Get full text
    Journal Article
  4. 4

    2SPD-021 Survey of drug shortages in Hungarian hospitals by Vida, RG, Sebők, S, Nyaka, B, Hornyák, J, Botz, L

    “…Background and importanceDrug shortages pose an enormous challenge to healthcare systems globally. However, the data available are limited, as there are 53…”
    Get full text
    Journal Article
  5. 5
  6. 6

    4CPS-129 Pilot study to survey the attitude, supplement use and storage conditions of drug products among patients receiving biological therapy by Vida, RG, Somogyi-Végh, A, Mayer, M, Kiss, D, Schaadt, N, Rajj, R, Molnár, B, Botz, L

    “…Background and importanceBiological therapies have recently become the cornerstone for the treatment of several dermatological and rheumatological diseases. As…”
    Get full text
    Journal Article
  7. 7

    2SPD-023 How much does falsified medicines directive actually costs? Detailed cost evaluation of serialisation in a representative sample of Hungarian hospital pharmacies by Fittler, A, Richter, K, Vajda, P, Bodrogi, Z, Vida, RG, Bella, R, Kovács, S, Zemplényi, A, Botz, L

    “…Background and importanceThe aim of the falsified medicines directive (FMD 2011/62/EU) is to prevent the entry of illegitimate medicines into the legal supply…”
    Get full text
    Journal Article
  8. 8

    DD-023 Evaluation of information content and characteristics of publicly available drug shortage information sources by Vida, RG, Fittler, A, Botz, L

    “…BackgroundAs drug shortages continue to pose an international problem almost every country has implemented a shortage information source in the form of a…”
    Get full text
    Journal Article